How do I buy Macrogenics (MGNX) stock?

You can purchase shares of Macrogenics (NASDAQ:MGNX) through any online brokerage.View our list of the best stock brokerages

Who are Macrogenics (MGNX) competitors?

Other companies in Macrogenics’s space includes: Tharimmune Inc (NASDAQ:THAR), Fortress Biotech Inc (NASDAQ:FBIO), Anixa Biosciences Inc (NASDAQ:ANIX), Inovio Pharmaceuticals Inc (NASDAQ:INO) and Fate Therapeutics Inc (NASDAQ:FATE).

What is the forecast, or price target, for Macrogenics (MGNX) stock?

Macrogenics has a consensus price target of $6.90.

What is the current price for Macrogenics (MGNX)?

The stock price for Macrogenics (NASDAQ: MGNX) is $1.74 last updated January 20, 2026 at 5:42 PM EST.

Does Macrogenics (MGNX) pay a dividend?

There are no upcoming dividends for Macrogenics.

When is Macrogenics (NASDAQ:MGNX) reporting earnings?

Macrogenics does not have any upcoming earnings scheduled.

Is Macrogenics (MGNX) going to split?

There is no upcoming split for Macrogenics.

What sector and industry does Macrogenics (MGNX) operate in?

Macrogenics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Macrogenics (MGNX) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast...

Comments